These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37293126)

  • 41. Interferon-α promotes MHC I antigen presentation of islet β cells through STAT1-IRF7 pathway in type 1 diabetes.
    Jiang H; Li Y; Shen M; Liang Y; Qian Y; Dai H; Xu K; Xu X; Lv H; Zhang J; Yang T; Fu Q
    Immunology; 2022 Jun; 166(2):210-221. PubMed ID: 35298836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated IFN-alpha/beta levels in a streptozotocin-induced type I diabetic mouse model promote oxidative stress and mediate depletion of spleen-homing CD8+ T cells by apoptosis through impaired CCL21/CCR7 axis and IL-7/CD127 signaling.
    Mahmoud MH; Badr G; Badr BM; Kassem AU; Mohamed MS
    Cell Signal; 2015 Oct; 27(10):2110-9. PubMed ID: 26192098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liraglutide Exerts Potential Anti-inflammatory Effect in Type 1 Diabetes by Inhibiting IFN-γ Production
    Zhao Y; Xie Y; Li W
    Endocr Metab Immune Disord Drug Targets; 2019; 19(5):656-664. PubMed ID: 30827273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IFN-γ treatment protocol for MHC-I
    Stifter K; Krieger J; Ruths L; Gout J; Mulaw M; Lechel A; Kleger A; Seufferlein T; Wagner M; Schirmbeck R
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32868392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.
    Coppieters KT; Amirian N; von Herrath MG
    Clin Exp Immunol; 2011 Aug; 165(2):155-62. PubMed ID: 21605113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
    Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
    J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon.
    Serreze DV; Wasserfall C; Ottendorfer EW; Stalvey M; Pierce MA; Gauntt C; O'Donnell B; Flanagan JB; Campbell-Thompson M; Ellis TM; Atkinson MA
    J Virol; 2005 Jan; 79(2):1045-52. PubMed ID: 15613333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
    Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
    Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sodium meta-arsenite prevents the development of autoimmune diabetes in NOD mice.
    Lee YS; Kim D; Lee EK; Kim S; Choi CS; Jun HS
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):254-61. PubMed ID: 25576766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC
    Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of Type I Interferon Subtypes and Interferon-Gamma in Type I Interferon Diabetes Inhibitory Activity in the NOD Mouse.
    Sobel D; Ahvazi B; Pontzer C
    J Interferon Cytokine Res; 2016 Apr; 36(4):238-46. PubMed ID: 26716812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.
    Serreze DV; Chapman HD; Post CM; Johnson EA; Suarez-Pinzon WL; Rabinovitch A
    J Immunol; 2001 Jan; 166(2):1352-9. PubMed ID: 11145720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetics of TNF-alpha and IFN-gamma mRNA expression in islets and spleen of NOD mice.
    Ventura-Oliveira D; Vilella CA; Zanin ME; Castro GM; Moreira Filho DC; Zollner RL
    Braz J Med Biol Res; 2002 Nov; 35(11):1347-55. PubMed ID: 12426635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction in insulitis following administration of IFN-gamma and TNF-alpha in the NOD mouse.
    Campbell IL; Oxbrow L; Harrison LC
    J Autoimmun; 1991 Apr; 4(2):249-62. PubMed ID: 1909136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes.
    Thomas HE; Parker JL; Schreiber RD; Kay TW
    J Clin Invest; 1998 Sep; 102(6):1249-57. PubMed ID: 9739059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection.
    Suarez-Ramirez JE; Tarrio ML; Kim K; Demers DA; Biron CA
    mBio; 2014 Oct; 5(5):e01978-14. PubMed ID: 25336459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile.
    Somoza N; Vargas F; Roura-Mir C; Vives-Pi M; Fernández-Figueras MT; Ariza A; Gomis R; Bragado R; Martí M; Jaraquemada D; Pujol-Borrell R
    J Immunol; 1994 Aug; 153(3):1360-77. PubMed ID: 7913115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interferons limit autoantigen-specific CD8
    Jhala G; Krishnamurthy B; Brodnicki TC; Ge T; Akazawa S; Selck C; Trivedi PM; Pappas EG; Mackin L; Principe N; Brémaud E; De George DJ; Boon L; Smyth I; Chee J; Kay TWH; Thomas HE
    Cell Rep; 2022 Apr; 39(4):110747. PubMed ID: 35476975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of autoimmune diabetes in non-obese diabetic mice requires interleukin-21-dependent activation of autoreactive CD8⁺ T cells.
    Chen XL; Bobbala D; Rodriguez GM; Mayhue M; Chen YG; Ilangumaran S; Ramanathan S
    Clin Exp Immunol; 2013 Aug; 173(2):184-94. PubMed ID: 23607664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.